APO Research
Talk to an analyst

APO RESEARCH · REPORT

Axillary Hyperhidrosis Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Axillary Hyperhidrosis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025188 pages

Choose your research edition.

Industry ResearchAxillary Hyperhidrosis Drug Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Axillary Hyperhidrosis Drug Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Axillary Hyperhidrosis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Axillary Hyperhidrosis Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Axillary Hyperhidrosis Drug Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Axillary Hyperhidrosis Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Axillary Hyperhidrosis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Axillary Hyperhidrosis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Axillary Hyperhidrosis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Axillary Hyperhidrosis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Axillary Hyperhidrosis Drug include GlaxoSmithKline Plc, TheraVida Inc, Dr. August Wolff GmbH & Co KG Arzneimittle, Dermira Inc, Brickell Biotech Inc and Allergan Plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Axillary Hyperhidrosis Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Axillary Hyperhidrosis Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Axillary Hyperhidrosis Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Axillary Hyperhidrosis Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Axillary Hyperhidrosis Drug Segment by Company

GlaxoSmithKline Plc

TheraVida Inc

Dr. August Wolff GmbH & Co KG Arzneimittle

Dermira Inc

Brickell Biotech Inc

Allergan Plc

Axillary Hyperhidrosis Drug Segment by Type

Botulinum ToxinA

Glycopyrronium Tosylate

Glycopyrrolate

Others

Axillary Hyperhidrosis Drug Segment by Application

Home Care

Hospital

Clinic

Axillary Hyperhidrosis Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Axillary Hyperhidrosis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Axillary Hyperhidrosis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Axillary Hyperhidrosis Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Axillary Hyperhidrosis Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Axillary Hyperhidrosis Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Axillary Hyperhidrosis Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Axillary Hyperhidrosis Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Axillary Hyperhidrosis Drug Industry Trends Table 2. Axillary Hyperhidrosis Drug Industry Drivers Table 3. Axillary Hyperhidrosis Drug Industry Opportunities and Challenges Table 4. Axillary Hyperhidrosis Drug Industry Restraints Table 5. Global Axillary Hyperhidrosis Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Axillary Hyperhidrosis Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Axillary Hyperhidrosis Drug Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Axillary Hyperhidrosis Drug Sales Market Share by Manufacturers Table 9. Global Axillary Hyperhidrosis Drug Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Axillary Hyperhidrosis Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Axillary Hyperhidrosis Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Axillary Hyperhidrosis Drug Manufacturers, Product Type & Application Table 13. Global Axillary Hyperhidrosis Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Axillary Hyperhidrosis Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Botulinum ToxinA Table 17. Major Manufacturers of Glycopyrronium Tosylate Table 18. Major Manufacturers of Glycopyrrolate Table 19. Major Manufacturers of Others Table 20. Global Axillary Hyperhidrosis Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Axillary Hyperhidrosis Drug Sales by Type (2021-2026) & (k units) Table 22. Global Axillary Hyperhidrosis Drug Sales by Type (2027-2032) & (k units) Table 23. Global Axillary Hyperhidrosis Drug Sales Market Share by Type (2021-2026) Table 24. Global Axillary Hyperhidrosis Drug Sales Market Share by Type (2027-2032) Table 25. Global Axillary Hyperhidrosis Drug Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Axillary Hyperhidrosis Drug Revenue by Type (2021-2026) & (k units) Table 27. Global Axillary Hyperhidrosis Drug Revenue by Type (2027-2032) & (k units) Table 28. Global Axillary Hyperhidrosis Drug Revenue Market Share by Type (2021-2026) Table 29. Global Axillary Hyperhidrosis Drug Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Home Care Table 31. Major Manufacturers of Hospital Table 32. Major Manufacturers of Clinic Table 33. Global Axillary Hyperhidrosis Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Axillary Hyperhidrosis Drug Sales by Application (2021-2026) & (k units) Table 35. Global Axillary Hyperhidrosis Drug Sales by Application (2027-2032) & (k units) Table 36. Global Axillary Hyperhidrosis Drug Sales Market Share by Application (2021-2026) Table 37. Global Axillary Hyperhidrosis Drug Sales Market Share by Application (2027-2032) Table 38. Global Axillary Hyperhidrosis Drug Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Axillary Hyperhidrosis Drug Revenue by Application (2021-2026) & (k units) Table 40. Global Axillary Hyperhidrosis Drug Revenue by Application (2027-2032) & (k units) Table 41. Global Axillary Hyperhidrosis Drug Revenue Market Share by Application (2021-2026) Table 42. Global Axillary Hyperhidrosis Drug Revenue Market Share by Application (2027-2032) Table 43. Global Axillary Hyperhidrosis Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Axillary Hyperhidrosis Drug Sales by Region (2021-2026) & (k units) Table 45. Global Axillary Hyperhidrosis Drug Sales Market Share by Region (2021-2026) Table 46. Global Axillary Hyperhidrosis Drug Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Axillary Hyperhidrosis Drug Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Axillary Hyperhidrosis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Axillary Hyperhidrosis Drug Sales by Country (2021-2026) & (k units) Table 50. North America Axillary Hyperhidrosis Drug Sales by Country (2027-2032) & (k units) Table 51. Europe Axillary Hyperhidrosis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Axillary Hyperhidrosis Drug Sales by Country (2021-2026) & (k units) Table 53. Europe Axillary Hyperhidrosis Drug Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Axillary Hyperhidrosis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Axillary Hyperhidrosis Drug Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Axillary Hyperhidrosis Drug Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Axillary Hyperhidrosis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Axillary Hyperhidrosis Drug Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Axillary Hyperhidrosis Drug Sales by Country (2027-2032) & (k units) Table 60. Global Axillary Hyperhidrosis Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Axillary Hyperhidrosis Drug Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Axillary Hyperhidrosis Drug Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Axillary Hyperhidrosis Drug Revenue Market Share by Region (2021-2026) Table 64. Global Axillary Hyperhidrosis Drug Revenue Market Share by Region (2027-2032) Table 65. GlaxoSmithKline Plc Company Information Table 66. GlaxoSmithKline Plc Business Overview Table 67. GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Product Portfolio Table 69. GlaxoSmithKline Plc Recent Development Table 70. TheraVida Inc Company Information Table 71. TheraVida Inc Business Overview Table 72. TheraVida Inc Axillary Hyperhidrosis Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. TheraVida Inc Axillary Hyperhidrosis Drug Product Portfolio Table 74. TheraVida Inc Recent Development Table 75. Dr. August Wolff GmbH & Co KG Arzneimittle Company Information Table 76. Dr. August Wolff GmbH & Co KG Arzneimittle Business Overview Table 77. Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Product Portfolio Table 79. Dr. August Wolff GmbH & Co KG Arzneimittle Recent Development Table 80. Dermira Inc Company Information Table 81. Dermira Inc Business Overview Table 82. Dermira Inc Axillary Hyperhidrosis Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Dermira Inc Axillary Hyperhidrosis Drug Product Portfolio Table 84. Dermira Inc Recent Development Table 85. Brickell Biotech Inc Company Information Table 86. Brickell Biotech Inc Business Overview Table 87. Brickell Biotech Inc Axillary Hyperhidrosis Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Brickell Biotech Inc Axillary Hyperhidrosis Drug Product Portfolio Table 89. Brickell Biotech Inc Recent Development Table 90. Allergan Plc Company Information Table 91. Allergan Plc Business Overview Table 92. Allergan Plc Axillary Hyperhidrosis Drug Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Allergan Plc Axillary Hyperhidrosis Drug Product Portfolio Table 94. Allergan Plc Recent Development Table 95. Key Raw Materials Table 96. Raw Materials Key Suppliers Table 97. Axillary Hyperhidrosis Drug Distributors List Table 98. Axillary Hyperhidrosis Drug Customers List Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Axillary Hyperhidrosis Drug Product Image Figure 2. Global Axillary Hyperhidrosis Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Axillary Hyperhidrosis Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Axillary Hyperhidrosis Drug Sales (2021-2032) & (k units) Figure 5. Global Axillary Hyperhidrosis Drug Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Axillary Hyperhidrosis Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Botulinum ToxinA Image Figure 9. Glycopyrronium Tosylate Image Figure 10. Glycopyrrolate Image Figure 11. Others Image Figure 12. Global Axillary Hyperhidrosis Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Axillary Hyperhidrosis Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Axillary Hyperhidrosis Drug Sales Market Share by Type (2021-2032) Figure 15. Global Axillary Hyperhidrosis Drug Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Axillary Hyperhidrosis Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Axillary Hyperhidrosis Drug Revenue Market Share by Type (2021-2032) Figure 18. Home Care Image Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Global Axillary Hyperhidrosis Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Axillary Hyperhidrosis Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Axillary Hyperhidrosis Drug Sales Market Share by Application (2021-2032) Figure 24. Global Axillary Hyperhidrosis Drug Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Axillary Hyperhidrosis Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Axillary Hyperhidrosis Drug Revenue Market Share by Application (2021-2032) Figure 27. North America Axillary Hyperhidrosis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Axillary Hyperhidrosis Drug Sales Market Share by Country (2021-2032) Figure 29. U.S. Axillary Hyperhidrosis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Axillary Hyperhidrosis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Axillary Hyperhidrosis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Axillary Hyperhidrosis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Axillary Hyperhidrosis Drug Sales Market Share by Country (2021-2032) Figure 34. Germany Axillary Hyperhidrosis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Axillary Hyperhidrosis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Axillary Hyperhidrosis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Axillary Hyperhidrosis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Axillary Hyperhidrosis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Axillary Hyperhidrosis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Axillary Hyperhidrosis Drug Sales Market Share by Country (2021-2032) Figure 41. China Axillary Hyperhidrosis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Axillary Hyperhidrosis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Axillary Hyperhidrosis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Axillary Hyperhidrosis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Axillary Hyperhidrosis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Axillary Hyperhidrosis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Axillary Hyperhidrosis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Axillary Hyperhidrosis Drug Sales Market Share by Country (2021-2032) Figure 49. Brazil Axillary Hyperhidrosis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Axillary Hyperhidrosis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Axillary Hyperhidrosis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Axillary Hyperhidrosis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Axillary Hyperhidrosis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Axillary Hyperhidrosis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Axillary Hyperhidrosis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Axillary Hyperhidrosis Drug Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Axillary Hyperhidrosis Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Axillary Hyperhidrosis Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Axillary Hyperhidrosis Drug Revenue (2021-2032) & (US$ Million) Figure 60. North America Axillary Hyperhidrosis Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Axillary Hyperhidrosis Drug Revenue (2021-2032) & (US$ Million) Figure 62. Europe Axillary Hyperhidrosis Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Axillary Hyperhidrosis Drug Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Axillary Hyperhidrosis Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Axillary Hyperhidrosis Drug Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Axillary Hyperhidrosis Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Axillary Hyperhidrosis Drug Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Axillary Hyperhidrosis Drug Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Botulinum ToxinA
  • Glycopyrronium Tosylate
  • Glycopyrrolate
  • Others
Applications
  • Home Care
  • Hospital
  • Clinic
Companies covered
  • GlaxoSmithKline Plc
  • TheraVida Inc
  • Dr. August Wolff GmbH & Co KG Arzneimittle
  • Dermira Inc
  • Brickell Biotech Inc
  • Allergan Plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Axillary Hyperhidrosis Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Axillary Hyperhidrosis Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Axillary Hyperhidrosis Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Axillary Hyperhidrosis Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Axillary Hyperhidrosis Drug Market Dynamics
  1. 2.1 Axillary Hyperhidrosis Drug Industry Trends
  2. 2.2 Axillary Hyperhidrosis Drug Industry Drivers
  3. 2.3 Axillary Hyperhidrosis Drug Industry Opportunities and Challenges
  4. 2.4 Axillary Hyperhidrosis Drug Industry Restraints
3 Axillary Hyperhidrosis Drug Market by Manufacturers
  1. 3.1 Global Axillary Hyperhidrosis Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Axillary Hyperhidrosis Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Axillary Hyperhidrosis Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Axillary Hyperhidrosis Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Axillary Hyperhidrosis Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Axillary Hyperhidrosis Drug Manufacturers, Product Type & Application
  7. 3.7 Global Axillary Hyperhidrosis Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Axillary Hyperhidrosis Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Axillary Hyperhidrosis Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Axillary Hyperhidrosis Drug Tier 1, Tier 2, and Tier 3
4 Axillary Hyperhidrosis Drug Market by Type
  1. 4.1 Axillary Hyperhidrosis Drug Type Introduction
  2. 4.1.1 Botulinum ToxinA
  3. 4.1.2 Glycopyrronium Tosylate
  4. 4.1.3 Glycopyrrolate
  5. 4.1.4 Others
  6. 4.2 Global Axillary Hyperhidrosis Drug Sales by Type
  7. 4.2.1 Global Axillary Hyperhidrosis Drug Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Axillary Hyperhidrosis Drug Sales by Type (2021-2032)
  9. 4.2.3 Global Axillary Hyperhidrosis Drug Sales Market Share by Type (2021-2032)
  10. 4.3 Global Axillary Hyperhidrosis Drug Revenue by Type
  11. 4.3.1 Global Axillary Hyperhidrosis Drug Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Axillary Hyperhidrosis Drug Revenue by Type (2021-2032)
  13. 4.3.3 Global Axillary Hyperhidrosis Drug Revenue Market Share by Type (2021-2032)
5 Axillary Hyperhidrosis Drug Market by Application
  1. 5.1 Axillary Hyperhidrosis Drug Application Introduction
  2. 5.1.1 Home Care
  3. 5.1.2 Hospital
  4. 5.1.3 Clinic
  5. 5.2 Global Axillary Hyperhidrosis Drug Sales by Application
  6. 5.2.1 Global Axillary Hyperhidrosis Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Axillary Hyperhidrosis Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Axillary Hyperhidrosis Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Axillary Hyperhidrosis Drug Revenue by Application
  10. 5.3.1 Global Axillary Hyperhidrosis Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Axillary Hyperhidrosis Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Axillary Hyperhidrosis Drug Revenue Market Share by Application (2021-2032)
6 Global Axillary Hyperhidrosis Drug Sales by Region
  1. 6.1 Global Axillary Hyperhidrosis Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Axillary Hyperhidrosis Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Axillary Hyperhidrosis Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Axillary Hyperhidrosis Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Axillary Hyperhidrosis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Axillary Hyperhidrosis Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Axillary Hyperhidrosis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Axillary Hyperhidrosis Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Axillary Hyperhidrosis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Axillary Hyperhidrosis Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Axillary Hyperhidrosis Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Axillary Hyperhidrosis Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Axillary Hyperhidrosis Drug Revenue by Region
  1. 7.1 Global Axillary Hyperhidrosis Drug Revenue by Region
  2. 7.1.1 Global Axillary Hyperhidrosis Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Axillary Hyperhidrosis Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Axillary Hyperhidrosis Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Axillary Hyperhidrosis Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Axillary Hyperhidrosis Drug Revenue (2021-2032)
  8. 7.2.2 North America Axillary Hyperhidrosis Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Axillary Hyperhidrosis Drug Revenue (2021-2032)
  11. 7.3.2 Europe Axillary Hyperhidrosis Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Axillary Hyperhidrosis Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Axillary Hyperhidrosis Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Axillary Hyperhidrosis Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Axillary Hyperhidrosis Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 GlaxoSmithKline Plc
  2. 8.1.1 GlaxoSmithKline Plc Company Information
  3. 8.1.2 GlaxoSmithKline Plc Business Overview
  4. 8.1.3 GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Product Portfolio
  6. 8.1.5 GlaxoSmithKline Plc Recent Developments
  7. 8.2 TheraVida Inc
  8. 8.2.1 TheraVida Inc Company Information
  9. 8.2.2 TheraVida Inc Business Overview
  10. 8.2.3 TheraVida Inc Axillary Hyperhidrosis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 TheraVida Inc Axillary Hyperhidrosis Drug Product Portfolio
  12. 8.2.5 TheraVida Inc Recent Developments
  13. 8.3 Dr. August Wolff GmbH & Co KG Arzneimittle
  14. 8.3.1 Dr. August Wolff GmbH & Co KG Arzneimittle Company Information
  15. 8.3.2 Dr. August Wolff GmbH & Co KG Arzneimittle Business Overview
  16. 8.3.3 Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Product Portfolio
  18. 8.3.5 Dr. August Wolff GmbH & Co KG Arzneimittle Recent Developments
  19. 8.4 Dermira Inc
  20. 8.4.1 Dermira Inc Company Information
  21. 8.4.2 Dermira Inc Business Overview
  22. 8.4.3 Dermira Inc Axillary Hyperhidrosis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Dermira Inc Axillary Hyperhidrosis Drug Product Portfolio
  24. 8.4.5 Dermira Inc Recent Developments
  25. 8.5 Brickell Biotech Inc
  26. 8.5.1 Brickell Biotech Inc Company Information
  27. 8.5.2 Brickell Biotech Inc Business Overview
  28. 8.5.3 Brickell Biotech Inc Axillary Hyperhidrosis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Brickell Biotech Inc Axillary Hyperhidrosis Drug Product Portfolio
  30. 8.5.5 Brickell Biotech Inc Recent Developments
  31. 8.6 Allergan Plc
  32. 8.6.1 Allergan Plc Company Information
  33. 8.6.2 Allergan Plc Business Overview
  34. 8.6.3 Allergan Plc Axillary Hyperhidrosis Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Allergan Plc Axillary Hyperhidrosis Drug Product Portfolio
  36. 8.6.5 Allergan Plc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Axillary Hyperhidrosis Drug Value Chain Analysis
  2. 9.1.1 Axillary Hyperhidrosis Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Axillary Hyperhidrosis Drug Production Mode & Process
  6. 9.2 Axillary Hyperhidrosis Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Axillary Hyperhidrosis Drug Distributors
  9. 9.2.3 Axillary Hyperhidrosis Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst